Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 27Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Regulations and guidelines governing stem cell based products: Clinical considerations

George Bobby

Year : 2011| Volume: 2| Issue : 3 | Page no: 94-99

   This article has been cited by
1 Acute toxicity analysis of Disarib, an inhibitor of BCL2
Shivangi Sharma,Kontham Kulangara Varsha,Susmita Kumari,Vidya Gopalakrishnan,Anjana Elizabeth Jose,Bibha Choudhary,Kempegowda Mantelingu,Sathees C. Raghavan
Scientific Reports. 2020; 10(1)
[Pubmed]  [Google Scholar] [DOI]
2 Regulatory considerations for developing a phase I investigational new drug application for autologous induced pluripotent stem cells -based therapy product
Balendu Shekhar Jha,Mitra Farnoodian,Kapil Bharti
STEM CELLS Translational Medicine. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 Past, Present, and Future of Affinity-based Cell Separation Technologies
Kaitlyn Bacon,Ashton Lavoie,Balaji M. Rao,Michael Daniele,Stefano Menegatti
Acta Biomaterialia. 2020;
[Pubmed]  [Google Scholar] [DOI]
4 Cardiac repair and the putative role of stem cells
L. Maximilian Buja
Journal of Molecular and Cellular Cardiology. 2019; 128: 96
[Pubmed]  [Google Scholar] [DOI]
5 Stem cell/cellular interventions in human spinal cord injury: Is it time to move from guidelines to regulations and legislations? Literature review and Spinal Cord Society position statement
Harvinder S. Chhabra,Kanchan Sarda,Geeta Jotwani,M. Gourie-Devi,Erkan Kaptanoglu,Susan Charlifue,S. L. Yadav,B. Mohapatra,Abhishek Srivastava,Kedar Phadke
European Spine Journal. 2019;
[Pubmed]  [Google Scholar] [DOI]
6 Reflection and observation: cell-based screening failing to detect HBV in HUMSCs derived from HBV-infected mothers underscores the importance of more stringent donor eligibility to reduce risk of transmission of infectious diseases for stem cell-based medical products
Wei Liu,Yuanyuan Xie,Tianyun Gao,Feifei Huang,Liudi Wang,Lijun Ding,Wenqing Wang,Shuo Liu,Jianwu Dai,Bin Wang
Stem Cell Research & Therapy. 2018; 9(1)
[Pubmed]  [Google Scholar] [DOI]
7 Improved Long-Term Volume Retention of Stromal Vascular Fraction Gel Grafting with Enhanced Angiogenesis and Adipogenesis
Yuteng Zhang,Junrong Cai,Tao Zhou,Yao Yao,Ziqing Dong,Feng Lu
Plastic and Reconstructive Surgery. 2018; 141(5): 676e
[Pubmed]  [Google Scholar] [DOI]
8 Considering Cell Therapy Product “Good Manufacturing Practice” Status
Patrick Bedford,Juliana Jy,Lucas Collins,Steven Keizer
Frontiers in Medicine. 2018; 5
[Pubmed]  [Google Scholar] [DOI]
9 Accreditation of Biosafe Clinical-Grade Human Embryonic Stem Cells According to Chinese Regulations
Qi Gu,Juan Wang,Lei Wang,Zheng-Xin Liu,Wan-Wan Zhu,Yuan-Qing Tan,Wei-Fang Han,Jun Wu,Chun-Jing Feng,Jin-Hui Fang,Lei Liu,Liu Wang,Wei Li,Xiao-Yang Zhao,Bao-Yang Hu,Jie Hao,Qi Zhou
Stem Cell Reports. 2017;
[Pubmed]  [Google Scholar] [DOI]
10 Clinical translation of stem cell based interventions for spinal cord injury- Are we there yet?
Harvinder S. Chhabra,Kanchan Sarda
Advanced Drug Delivery Reviews. 2017;
[Pubmed]  [Google Scholar] [DOI]
11 Stem Cell Therapy on the Internet: Information Quality and Content Analysis of English Language Web Pages Returned by Google
Douglas Meehan,Isabella Harb Bizzi,Pietro Ghezzi
Frontiers in ICT. 2017; 4
[Pubmed]  [Google Scholar] [DOI]
12 The potential impact of bone tissue engineering in the clinic
Ruchi Mishra,Tyler Bishop,Ian L Valerio,John P Fisher,David Dean
Regenerative Medicine. 2016; 11(6): 571
[Pubmed]  [Google Scholar] [DOI]
13 Microparticles to enhance delivery of drugs and growth factors into wound sites
Sanjeev Ranjan,Flavia Fontana,Hanif Ullah,Jouni Hirvonen,Hélder A Santos
Therapeutic Delivery. 2016; 7(10): 711
[Pubmed]  [Google Scholar] [DOI]
14 Evaluating the Safety of Somatic Periosteal Cells by Flow-Cytometric Analysis Monitoring the History of DNA Damage
Tomoyuki Kawase,Kazuhide Hayama,Makoto Tsuchimochi,Masaki Nagata,Kazuhiro Okuda,Hiromasa Yoshie,Douglas M. Burns,Koh Nakata
Biopreservation and Biobanking. 2016;
[Pubmed]  [Google Scholar] [DOI]
15 Insight on stem cell preconditioning and instructive biomaterials to enhance cell adhesion, retention, and engraftment for tissue repair
Muhammad Shafiq,Youngmee Jung,Soo Hyun Kim
Biomaterials. 2016; 90: 85
[Pubmed]  [Google Scholar] [DOI]
16 Endpoints in stem cell trials in ischemic heart failure
Marko Banovic,Zlatibor Loncar,Atta Behfar,Marc Vanderheyden,Branko Beleslin,Andreas Zeiher,Marco Metra,Andre Terzic,Jozef Bartunek
Stem Cell Research & Therapy. 2015; 6(1)
[Pubmed]  [Google Scholar] [DOI]
17 Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis
Marek Barczyk,Matthias Schmidt,Sabrina Mattoli
Stem Cell Reviews and Reports. 2015; 11(4): 598
[Pubmed]  [Google Scholar] [DOI]
18 X-ray and ultraviolet C irradiation–induced ?-H2AX and p53 formation in normal human periosteal cells in vitro: markers for quality control in cell therapy
Tomoyuki Kawase,Mana Kamiya,Kazuhide Hayama,Masaki Nagata,Kazuhiro Okuda,Hiromasa Yoshie,Douglas M. Burns,Makoto Tsuchimochi,Koh Nakata
Cytotherapy. 2014;
[Pubmed]  [Google Scholar] [DOI]
19 The regulatory sciences for stem cell-based medicinal products
Bao-Zhu Yuan,Junzhi Wang
Frontiers of Medicine. 2014;
[Pubmed]  [Google Scholar] [DOI]
20 Cellular reprogramming for understanding and treating human disease
Riya R. Kanherkar,Naina Bhatia-Dey,Evgeny Makarev,Antonei B. Csoka
Frontiers in Cell and Developmental Biology. 2014; 2
[Pubmed]  [Google Scholar] [DOI]
21 Stem Cells, Dot-Com
B. A. Liang,T. K. Mackey
Science Translational Medicine. 2012; 4(151): 151cm9
[Pubmed]  [Google Scholar] [DOI]
22 Peptidhydrogele für den Einsatz von Stammzellen in der regenerativen Medizin
C.A.E. Hauser,Y.E. Loo
Gynäkologische Endokrinologie. 2012; 10(4): 255
[Pubmed]  [Google Scholar] [DOI]


Read this article